Marché allemand des kits de test à domicile – Tendances et prévisions du secteur jusqu’en 2030

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché allemand des kits de test à domicile – Tendances et prévisions du secteur jusqu’en 2030

  • Healthcare
  • Publish Reports
  • May 2023
  • Country Level
  • 350 Pages
  • Nombre de tableaux : 25
  • Nombre de figures : 41

Germany At Home Testing Kits Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
2024 –2030
Diagram Taille du marché (année de référence)
MILLIONS DE DOLLARS AMÉRICAINS
Diagram Taille du marché (année de prévision)
MILLIONS DE DOLLARS AMÉRICAINS
Diagram TCAC
%
DiagramPrincipaux acteurs du marché
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5 < /li>

Marché allemand des kits de test à domicile, par type de test (beauté et bien-être, santé, nutrition, test de grossesse, test MST, kit de test de prédiction d'ovulation, kit de test de toxicomanie et autres types de tests), type (cassette, bandelette, test intermédiaire, panneau de test, carte à immersion et autres), âge (pédiatrique, adulte et gériatrique), type d'échantillon (urine, sang, salive et autres types d'échantillons), revenu (faible revenu, revenu moyen et revenu élevé), utilisation (jetable et réutilisable), canaux de distribution (pharmacies de détail, pharmacies, supermarchés/hypermarchés et pharmacies en ligne) - Tendances et prévisions de l'industrie jusqu'en 2030.

Analyse et taille du marché des kits de test à domicile en Allemagne

Le marché allemand des kits de test à domicile devrait croître en raison de la sensibilisation croissante à plusieurs produits. Les kits de test à domicile ou d'auto-test sont facilement disponibles dans les pharmacies et leur achat est devenu extrêmement facile. Diverses sociétés médicales se lancent dans ce domaine en fabriquant rapidement des kits d'auto-test.Marché allemand des kits de test à domicileMarché allemand des kits de test à domicile

Cette disponibilité généralisée peut également être attribuée aux start-ups médicales des pharmacies en ligne, qui facilitent l'accès au médicament en un clic. De plus, ces kits d'auto-test sont disponibles sans ordonnance, ce qui peut stimuler le marché des kits de test à domicile. Les kits de test à domicile permettent aux utilisateurs finaux de prélever leur échantillon à domicile et de l'effectuer à domicile ou de l'envoyer au laboratoire pour analyse. Les kits de test à domicile ont sans aucun doute facilité le processus de confirmation de l'inquiétude de la personne, qu'il s'agisse d'un test de grossesse à domicile ou du VIH, ou de tout autre test de maladie infectieuse.

Ces tests à domicile sont faciles à utiliser et abordables. Cependant, il existe toujours des doutes sur l'exactitude des résultats, ce qui devrait freiner la croissance du marché. Cependant, un résultat de test faussement positif peut provoquer de l'anxiété et du stress chez la personne, même si elle ne l'a pas. Il est très bouleversant et dérangeant pour la personne de recevoir des résultats faussement positifs ou négatifs. Aujourd'hui, de nombreuses entreprises produisent des kits de test de diagnostic rapide pour le COVID-19, qui peuvent être effectués à domicile. Mais il existe divers problèmes liés à la précision, de sorte que la distribution de ces kits de test à domicile a été suspendue pour vérifier leur fiabilité.

Data Bridge Market Research analyse que le marché allemand des kits de test à domicile devrait croître à un TCAC de 10,5 % entre 2023 et 2030.

Rapport métrique

Détails

Période de prévision

2023 à 2030

Année de base

2022

Année historique

2021 (personnalisable de 2015 à 2020)

Unités quantitatives

Chiffre d'affaires en millions et prix en USD

Segments couverts

Type de test (beauté et bien-être, santé, nutrition, test de grossesse, test MST, kit de test de prédiction d'ovulation, kit de test de toxicomanie et autres types de tests), type (cassette, bandelette, test intermédiaire, panel de test, carte à immersion et autres), âge (pédiatrique, adulte et gériatrique), type d'échantillon (urine, sang, salive et autres types d'échantillons), revenu (faible revenu, revenu moyen et revenu élevé), utilisation (jetable et réutilisable), canaux de distribution (pharmacies de détail, parapharmacies, supermarchés/hypermarchés et pharmacies en ligne)

Country Covered

Germany

Market Players Covered

Abbott, Siemens Healthcare GmbH, F. Hoffman- La Roche Ltd, Quidel Corporation, Cardinal Health, bioLytical Laboratories Inc., kiweno GmbH, Nova Biomedical, Johnson & Johnson Services, Inc., and B. Braun SE among others

Market Definition

At-home testing kits help the person to perform tests at home and give them rapid results in a minute. They also include monitoring equipment to check and control the health of diabetic patients continuously. At-home tests are convenient to perform comfortably and are available at a very affordable rate. Self-tests are usually the advanced versions of rapid, point-of-care test kits originally designed for healthcare professionals and can be performed by the common person. Their processes, packaging, and instructions have been simplified to guide a person through the steps of taking a test. Various at-home test kits are available, including beauty test kits, H.I.V. tests, pregnancy tests, diabetes, ovulation test, and infectious diseases such as malaria, influenza, and others. Blood, urine, and oral fluid can be taken as a sample for performing these rapid at-home tests.

Germany At-Home Testing Kits Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

  • Rise in the adoption of at-home testing kits due to the increase in the prevalence of health disorders

With rising economic growth, people are more interested in long-term health and wellness. Diabetic patients need devices to monitor their sugar levels; checking pregnancy increases the demand for pregnancy strips; monitoring of blood pressure results in demand for devices such as blood pressure monitors and sphygmomanometers; stress and anxiety increase the demand for stress test kits and others. Along with managing the disorder, it also helps check skin and other body-related issues such as allergies.

Earlier, people often visited hospitals/clinics/diagnostic centers for basic problems. However, as awareness has grown regarding several products, such as at-home testing kits for beauty and wellness, health, nutrition, and others, this behavior has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor or technician.

This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has become a boon in disguise for hospitals/clinics/ diagnostic centers and patients, as hospitals/clinics/diagnostic centers are already stretched thin and can entirely focus on COVID-19 patients. The patients can save hefty costs of doctor visits and medicine fees. It has become highly convenient for consumers as they can quickly know their test results at their fingertips.

Thus, the rising adoption of at-home testing kits due to convenience and rapid results is expected to drive market growth.

  • Easy availability of self-testing kits at pharmacies and online stores

At-home or self-testing kits are easily available at pharmacy stores and online stores, and it has become effortless to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits.

This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription.

Specialty online shops, emerging digital marketplaces, e-commerce, and internet advertising are further attracting the market. Online stores provide much-needed privacy options with doorstep delivery, widening their market reach.

Thus, self-testing kits have become widely available for various diseases due to the rapid manufacturing by medical testing companies and are expected to drive market growth.

Marché allemand des kits de test à domicile

Opportunity

  • Expanding business through subsidiaries

Companies operate their business through subsidiaries around the world. This would help the company to generate more revenue by serving a large customer base through its subsidiaries, which will create the opportunity for the company to expand its business and generate more revenue. Players with a major percentage share in the market alone are continuously expanding the health wellness business through their subsidiaries; they have a presence almost globally. This helps them to attract more customers and create a database of customers across various regions, ultimately helping them to identify the region and countries which require more focus and plans for helping the healthcare customers to make structural decisions.

This syndicates that the company is operating its business through its number of subsidiaries in different regions of the world. This helped the company generate more revenue and create an opportunity for market growth.

Restraint/Challenge

  • Inaccuracy of results by self-testing kits

At-home testing kits allow end-users to collect their specimen at home and perform it at home or send it to the lab for testing. At-home testing kits have undoubtedly eased the process of confirming the person's concern, whether it is a home pregnancy test or HIV, or any other infectious diseases tests.

These home tests are easy to use and affordable too. However, there is always doubt about the accuracy of the results. STD home monitoring can be more comfortable than visiting a hospital or doctor's office. It will also help reduce the risk of the STD being spread or acquired when you are screened.

However, a false-positive test result may cause anxiety and stress to the person, even if they do not have it. It is very upsetting and disturbing to the person to receive false positive or negative results. Today, many companies produce rapid diagnostic test kits for STDs, diabetes, and others, which can be performed at home. But there are various accuracy-related issues, so the distribution of those at-home test kits has been suspended from verifying their reliability.

Various factors can cause false results, such as manufacturing defects, low feasibility, incorrect instructions, or misinterpreting results.

Thus, end-users doubt the reliability of the rapid home testing kits, which is expected to restrain the market growth.

Recent Development

  • In April 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) had cleared a reader for its FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system, which features the world's smallest, thinnest, and most discreet5 glucose sensor. With the FDA's clearance of a standalone reader, the company will have expected to generate more revenue.

Germany At-Home Testing Kits Market Scope

Germany at-home testing kits market is categorized into seven notable segments based on test type, type, income, age, sample type, usage, and distribution channels. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Test Type

  • Beauty and Wellness
  • Health
  • Nutrition
  • Pregnancy Test
  • STD Test Kit
  • Ovulation Predictor Test Kit
  • Drug Abuse Test Kit
  • Others Test Types

On the basis of test type, the market is segmented into beauty and wellness, health, nutrition, pregnancy test, STD test kit, ovulation predictor test kit, drug abuse test kit, and other test types.

Type

  • Cassette
  • Strip
  • Midstream
  • Test Panel
  • Dip Card
  • Others

On the basis of type, the market is segmented into cassette, strip, midstream, test panel, dip card, and others.

Income

  • Low Income
  • Middle Income
  • High Income

On the basis of income, the market is segmented into low income, middle income, and high income.

Age

  • Pediatric
  • Adult
  • Geriatric

On the basis of age, the market is segmented into pediatric, adult, and geriatric.

Sample Type

  • Urine
  • Blood
  • Saliva
  • Other Sample Types

On the basis of sample type, the market is segmented into urine, blood, saliva, and others sample types.

Usage

  • Disposable
  • Reusable

On the basis of usage, the market is segmented into disposable and reusable.

Distribution Channels

  • Retail Pharmacies
  • Drug Store
  • Supermarket/Hypermarket
  • Online Pharmacies

On the basis of distribution channels, the market is segmented into retail pharmacies, drug store, supermarket/hypermarket, and online pharmacies.

Marché allemand des kits de test à domicile

Competitive Landscape and Germany At-Home Testing Kits Market Share Analysis

Le paysage concurrentiel du marché allemand des kits de test à domicile fournit des détails sur les concurrents. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence dans le pays, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais cliniques, l'analyse de la marque, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus ne concernent que l'orientation des entreprises sur le marché.

Certains des principaux acteurs du marché opérant sur le marché allemand des kits de test à domicile sont Abbott, Siemens Healthcare GmbH, F. Hoffman-La Roche Ltd, Quidel Corporation, Cardinal Health, bioLytical Laboratories Inc., kiweno GmbH, Nova Biomedical, Johnson & Johnson Services, Inc. et B. Braun SE, entre autres.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GERMANY AT-HOME TESTING KITS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE

2.8 MARKET POSITION COVERAGE GRID

2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.1 DBMR MARKET POSITION GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

4.3 STRATEGIC INITIATIVES

4.4 BRAND ANALYSIS

4.5 PRICING ANALYSIS

5 GERMANY AT-HOME TESTING KITS MARKET: REGULATIONS

5.1 REGULATION IN EUROPE

5.2 GUIDELINES FOR TESTING KITS

6 GERMANY AT-HOME TESTING KITS MARKET, MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISE IN THE ADOPTION OF AT-HOME TESTING KITS DUE TO THE INCREASE IN THE PREVALENCE OF HEALTH DISORDERS

6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES AND ONLINE STORES

6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF STD DIAGNOSIS

6.1.4 LOW COST AND EASE TO USE AT-HOME TEST KITS

6.2 RESTRAINTS

6.2.1 PRODUCT RECALL OF AT-HOME TESTING KITS

6.2.2 INACCURACY OF RESULTS BY SELF-TESTING KITS

6.2.3 STRINGENT GOVERNMENT REGULATIONS FOR THE MANUFACTURING AND DISTRIBUTION OF TESTING KITS

6.3 OPPORTUNITIES

6.3.1 EXPANDING BUSINESS THROUGH SUBSIDIARIES

6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS

6.4 CHALLENGES

6.4.1 LOW AWARENESS IN SOCIETY

6.4.2 REDUCTION IN THE R&D BUDGET

7 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE

7.1 OVERVIEW

7.2 HEALTH

7.2.1 DIABETES KITS

7.2.2 KIDNEY FUNCTION TEST KITS

7.2.3 LIVER FUNCTION TEST KITS

7.2.4 PROTEIN KITS

7.2.5 IRON STATUS KITS

7.2.6 HEART DISEASE RISK TEST KITS

7.2.7 THYROID FUNCTION

7.2.8 RED BLOOD CELLS

7.2.9 WHITE BLOOD CELLS

7.2.10 CLOTTING STATUS

7.2.11 HORMONE

7.2.12 PSA

7.2.13 MENOPAUSE TEST

7.2.14 ANXIETY

7.2.15 ASTHMA

7.2.16 ATRIAL FIBRILLATION

7.2.17 GOUT

7.2.18 HDL AND LDL CHOLESTROL TEST KITS

7.2.19 HIGH BLOOD PRESSURE

7.2.20 OTHERS

7.3 BEAUTY AND WELLNESS

7.3.1 SKIN MICROBIME TEST

7.3.2 GENETIC BASED TEST KITS

7.3.3 FOOD SENSITIVITY TEST KITS

7.3.4 SEX HORMONE

7.3.4.1 FEMALE HORMONE TEST

7.3.4.2 MALE HORMONE TEST

7.3.5 HAIR, NAILS AND SKIN TEST KITS

7.3.6 STRESS TEST KITS

7.3.7 ALCOHOL FLUSH REACTION

7.3.8 CAFFEINE CONSUMPTION

7.3.9 DEEP SLEEP

7.3.10 MUSCLE COMPOSITION

7.3.11 SATURATED FAT

7.3.12 SLEEP MOVEMENT

7.3.13 ALLERGY TESTING

7.3.14 INTOLERANCE TESTING

7.3.14.1 LACTOSE INTOLERANCE

7.3.14.2 VEGAN INTOLERANCE TESTING

7.3.14.3 OTHER TEST

7.3.15 GUT MICROBIOME TEST

7.3.16 SKIN DNA TEST

7.4 STD TEST

7.4.1 HIV TEST

7.4.2 GONORRHEA TEST

7.4.3 SYPHILIS TEST

7.4.4 HERPES TEST

7.4.5 TRICHOMONIASIS

7.4.6 HEPATITIS B

7.4.7 HEPATITIS C

7.4.8 MEASLES

7.4.9 RUBELLA

7.4.10 VARICELLA

7.4.11 CHLAMYDIA TEST

7.4.12 OTHERS

7.5 NUTRITION

7.5.1 VITAMINS

7.5.1.1 D3

7.5.1.2 B12

7.5.1.3 ACTIVE B12

7.5.2 VITALITY

7.5.2.1 HEALTH MARKERS

7.5.2.2 IRON STATUS

7.5.2.3 MINERALS

7.5.3 OMEGA 3 TEST

7.5.4 IODINE DEFICIENCY TEST

7.5.5 ZINC TEST

7.5.6 SELENIUM TEST

7.5.7 MAGNESIUM BLOOD TEST

7.5.8 FERRITIN TEST

7.5.9 AMINO ACID TEST

7.6 PREGNANCY TEST

7.6.1 STRIP TESTS

7.6.2 MIDSTREAM TEST

7.6.3 CASSETTE TEST

7.6.4 DIGITAL TEST

7.6.5 HCG URINE TEST

7.6.6 HCG BLOOD TEST

7.6.7 LH URINE TEST

7.6.8 FSH URINE TEST

7.7 DRUG ABUSE TEST KITS

7.7.1 MARUUANA KITS

7.7.2 OPIATES KITS

7.7.3 ALCOHOL KITS

7.7.4 OTHERS

7.8 OVULATION PREDICTOR TEST KIT

7.9 OTHERS TEST TYPES

7.9.1 MALE INFERTILITY TEST TYPE

7.9.2 URINARY TRACT INFECTIONS TEST

7.9.3 MENOPAUSE TEST KITS

7.9.4 FECAL OCCULT BLOOD TEST

7.9.5 OTHERS

8 GERMANY AT-HOME TESTING KITS MARKET, BY TYPE

8.1 OVERVIEW

8.2 STRIP

8.2.1 RETAIL PHARMACIES

8.2.2 ONLINE PHARMACIES

8.2.3 DRUG STORE

8.2.4 SUPERMARKET/HYPERMARKET

8.2.5 CASSETTES

8.2.6 RETAIL PHARMACIES

8.2.7 ONLINE PHARMACIES

8.2.8 DRUG STORE

8.2.9 SUPERMARKET/HYPERMARKET

8.2.10 MIDSTREAM

8.2.11 RETAIL PHARMACIES

8.2.12 ONLINE PHARMACIES

8.2.13 DRUG STORE

8.2.14 SUPERMARKET/HYPERMARKET

8.2.15 DIP CARD

8.2.16 RETAIL PHARMACIES

8.2.17 ONLINE PHARMACIES

8.2.18 DRUG STORE

8.2.19 SUPERMARKET/HYPERMARKET

8.2.20 TEST PANEL

8.2.21 RETAIL PHARMACIES

8.2.22 ONLINE PHARMACIES

8.2.23 DRUG STORE

8.2.24 SUPERMARKET/HYPERMARKET

8.3 OTHERS

9 GERMANY AT-HOME TESTING KITS MARKET, BY AGE

9.1 OVERVIEW

9.2 ADULT

9.3 GERIATRIC

9.4 PEDIATRIC

10 GERMANY AT-HOME TESTING KITS MARKET, BY USAGE

10.1 OVERVIEW

10.2 DISPOSABLE

10.3 REUSABLE

11 GERMANY AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE

11.1 OVERVIEW

11.2 BLOOD

11.3 SALIVA

11.4 URINE

11.5 OTHER SAMPLE TYPES

12 GERMANY AT-HOME TESTING KITS MARKET, BY INCOME

12.1 OVERVIEW

12.2 MIDDLE INCOME

12.3 LOW INCOME

12.4 HIGH INCOME

13 GERMANY AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 RETAIL PHARMACIES

13.3 ONLINE PHARMACIES

13.4 DRUG STORE

13.5 SUPERMARKET/HYPERMARKET

14 GERMANY AT-HOME TESTING KITS MARKET, COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 ABBOTT

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUS ANALYSIS

16.1.3 PRODUCT PORTFOLIO

16.1.4 RECENT DEVELOPMENTS

16.2 F. HOFFMANN- LA ROCHE LTD

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 PRODUCT PORTFOLIO

16.2.4 RECENT DEVELOPMENT

16.3 SIEMENS HEALTHCARE GMBH

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 PRODUCT PORTFOLIO

16.3.4 RECENT DEVELOPMENTS

16.4 QUIDEL CORPORATION.

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 PRODUCT PORTFOLIO

16.4.4 RECENT DEVELOPMENT

16.5 CARDINAL HEALTH.

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENTS

16.6 ASCENSIA DIABETES CARE HOLDINGS AG.

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 B. BRAUN SE MELSUNGEN AG

16.7.1 COMPANY SNAPSHOT

16.7.2 REVENUE ANALYSIS

16.7.3 PRODUCT PORTFOLIO

16.7.4 RECENT DEVELOPMENTS

16.8 BIOLYTICAL LABORATORIES INC.

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 BTNX INC.

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 CARE DIAGNOSTICA

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 DEXCOM, INC.

16.11.1 COMPANY SNAPSHOT

16.11.2 REVENUE ANALYSIS

16.11.3 PRODUCT PORTFOLIO

16.11.4 RECENT DEVELOPMENTS

16.12 DRÄGERWERK AG & CO. KGAA

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 JOHNSON & JOHNSON SERVICES, INC.

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 PRODUCT PORTFOLIO

16.13.4 RECENT DEVELOPMENTS

16.14 KIWENO GMBH

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 MP BIOMEDICALS.

16.15.1 COMPANY SNAPSHOT

16.15.2 PRODUCT PORTFOLIO

16.15.3 RECENT DEVELOPMENTS

16.16 NOVA BIOMEDICAL

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENT

16.17 PIRAMAL ENTERPRISES LTD.

16.17.1 COMPANY SNAPSHOT

16.17.2 REVENUE ANALYSIS

16.17.3 PRODUCT PORTFOLIO

16.17.4 RECENT DEVELOPMENTS

16.18 PRIMA LAB SA

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENTS

16.19 SELFDIAGNOSTICS OU

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 SA SCIENTIFIC LTD.

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

Liste des tableaux

TABLE 1 PRICES OF PRODUCTS OFFERED BY SOME OF THE COMPANIES:

TABLE 2 GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 3 GERMANY HEALTH IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 4 GERMANY BEAUTY AND WELLNESS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 5 GERMANY SEX HORMONE IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 6 GERMANY INTOLERANCE TESTING IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 7 GERMANY STD TEST IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 8 GERMANY NUTRITION IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 9 GERMANY VITAMINS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 10 GERMANY VITALITY IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 11 GERMANY PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY PRODUCT, 2021-2030 (USD MILLION), 2021-2030 (USD MILLION)

TABLE 12 GERMANY PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 13 GERMANY DRUG ABUSE TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 14 GERMANY OTHER TEST TYPE IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 15 GERMANY AT-HOME TESTING KITS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 16 GERMANY STRIP IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)

TABLE 17 GERMANY CASSETTES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)

TABLE 18 GERMANY MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)

TABLE 19 GERMANY MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)

TABLE 20 GERMANY MIDSTREAM IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS, 2021-2030 (USD MILLION)

TABLE 21 GERMANY AT-HOME TESTING KITS MARKET, BY AGE, 2021-2030 (USD MILLION)

TABLE 22 GERMANY AT-HOME TESTING KITS MARKET, BY USAGE, 2021-2030 (USD MILLION)

TABLE 23 GERMANY AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)

TABLE 24 GERMANY AT-HOME TESTING KITS MARKET, BY INCOME, 2021-2030 (USD MILLION)

TABLE 25 GERMANY AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

Liste des figures

FIGURE 1 GERMANY AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 2 GERMANY AT-HOME TESTING KITS MARKET: DATA TRIANGULATION

FIGURE 3 GERMANY AT-HOME TESTING KITS MARKET: DROC ANALYSIS

FIGURE 4 GERMANY AT-HOME TESTING KITS MARKET: GERMANY VS REGIONAL MARKET ANALYSIS

FIGURE 5 GERMANY AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GERMANY AT-HOME TESTING KITS MARKET: MARKET POSITION COVERAGE GRID

FIGURE 7 GERMANY AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GERMANY AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GERMANY AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 10 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES AND ONLINE STORES IS EXPECTED TO DRIVE GERMANY AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 11 HEALTH SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF GERMANY AT-HOME TESTING KITS MARKET, BY TEST TYPE IN 2023 & 2030

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GERMANY AT HOME TESTING KITS MARKET

FIGURE 13 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2022

FIGURE 14 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION)

FIGURE 15 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2023-2030)

FIGURE 16 GERMANY AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 17 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, 2022

FIGURE 18 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, 2021-2030 (USD MILLION)

FIGURE 19 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, CAGR (2023-2030)

FIGURE 20 GERMANY AT-HOME TESTING KITS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 21 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, 2022

FIGURE 22 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, 2023-2030 (USD MILLION)

FIGURE 23 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2023-2030)

FIGURE 24 GERMANY AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE

FIGURE 25 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, 2022

FIGURE 26 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, 2023-2030 (USD MILLION)

FIGURE 27 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, CAGR (2023-2030)

FIGURE 28 GERMANY AT-HOME TESTING KITS MARKET: BY USAGE, LIFELINE CURVE

FIGURE 29 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2022

FIGURE 30 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, 2021-2030 (USD MILLION)

FIGURE 31 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, CAGR (2023-2030)

FIGURE 32 GERMANY AT-HOME TESTING KITS MARKET: BY SAMPLE TYPE, LIFELINE CURVE

FIGURE 33 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, 2022

FIGURE 34 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, 2021-2030 (USD MILLION)

FIGURE 35 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, CAGR (2023-2030)

FIGURE 36 GERMANY AT-HOME TESTING KITS MARKET: BY INCOME, LIFELINE CURVE

FIGURE 37 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 38 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 39 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 40 GERMANY AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 41 GERMANY AT-HOME TESTING KITS MARKET: COMPANY SHARE 2022 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The Germany At-Home Testing Kits Market is projected to grow at a CAGR of 10.5% during the forecast period by 2030.
The major players in the Germany At-Home Testing Kits Market are Abbott, Siemens Healthcare GmbH, F. Hoffman- La Roche Ltd, Quidel Corporation, Cardinal Health, bioLytical Laboratories Inc., kiweno GmbH, Nova Biomedical, Johnson & Johnson Services, Inc., etc.
The Germany At-Home Testing Kits Market is segmented on the basis of test type, type, income, age, sample type, usage, and distribution channels.
Various factors can cause false results, such as manufacturing defects, low feasibility, incorrect instructions, or misinterpreting results